| 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk The Task Force for the management of … F Mach, C Baigent, AL Catapano, KC Koskinas, M Casula, L Badimon, ... European heart journal 41 (1), 111-188, 2020 | 8154 | 2020 |
| Rivaroxaban with or without aspirin in patients with stable peripheral or carotid artery disease: an international, randomised, double-blind, placebo-controlled trial SS Anand, J Bosch, JW Eikelboom, SJ Connolly, R Diaz, P Widimsky, ... The Lancet 391 (10117), 219-229, 2018 | 926 | 2018 |
| Worldwide experience with a totally subcutaneous implantable defibrillator: early results from the EFFORTLESS S-ICD Registry PD Lambiase, C Barr, DAMJ Theuns, R Knops, P Neuzil, JB Johansen, ... European heart journal 35 (25), 1657-1665, 2014 | 477 | 2014 |
| Valsartan for prevention of recurrent atrial fibrillation P Delise, F Bertocchi, G Maiocchi, E Geraci, E Correale, F Lombardi, ... New England Journal of Medicine 360 (16), 1606-1617, 2009 | 471 | 2009 |
| Presence and duration of atrial fibrillation detected by continuous monitoring: crucial implications for the risk of thromboembolic events GL Botto, L Padeletti, M Santini, A Capucci, M Gulizia, F Zolezzi, S Favale, ... Journal of cardiovascular electrophysiology 20 (3), 241-248, 2009 | 463 | 2009 |
| Monitored atrial fibrillation duration predicts arterial embolic events in patients suffering from bradycardia and atrial fibrillation implanted with antitachycardia pacemakers A Capucci, M Santini, L Padeletti, M Gulizia, GL Botto, G Boriani, R Ricci, ... Journal of the American College of Cardiology 46 (10), 1913-1920, 2005 | 446 | 2005 |
| Rivaroxaban with or without aspirin in patients with stable coronary artery disease: an international, randomised, double-blind, placebo-controlled trial SJ Connolly, JW Eikelboom, J Bosch, G Dagenais, L Dyal, F Lanas, ... The Lancet 391 (10117), 205-218, 2018 | 398 | 2018 |
| The changing landscape for stroke prevention in AF: findings from the GLORIA-AF registry phase 2 MV Huisman, KJ Rothman, M Paquette, C Teutsch, HC Diener, SJ Dubner, ... Journal of the American College of Cardiology 69 (7), 777-785, 2017 | 338 | 2017 |
| Comprehensive risk reduction in patients with atrial fibrillation: emerging diagnostic and therapeutic options—a report from the 3rd Atrial Fibrillation Competence NETwork … P Kirchhof, GYH Lip, IC Van Gelder, J Bax, E Hylek, S Kaab, U Schotten, ... Europace 14 (1), 8-27, 2012 | 336 | 2012 |
| Management of dyslipidaemia in patients with coronary heart disease: results from the ESC-EORP EUROASPIRE V survey in 27 countries G De Backer, P Jankowski, K Kotseva, E Mirrakhimov, Ž Reiner, L Ryden, ... Atherosclerosis 285, 135-146, 2019 | 303 | 2019 |
| Improving Stroke Risk Stratification Using the CHADS2 and CHA2DS2-VASc Risk Scores in Patients With Paroxysmal Atrial Fibrillation by Continuous Arrhythmia … G Boriani, GL Botto, L Padeletti, M Santini, A Capucci, M Gulizia, R Ricci, ... Stroke 42 (6), 1768-1770, 2011 | 261 | 2011 |
| Antithrombotic management in patients undergoing electrophysiological procedures: a European Heart Rhythm Association (EHRA) position document endorsed by the ESC working group … C Sticherling, F Marin, D Birnie, G Boriani, H Calkins, GA Dan, M Gulizia, ... Ep Europace 17 (8), 1197-1214, 2015 | 243 | 2015 |
| Personalized management of atrial fibrillation: Proceedings from the fourth Atrial Fibrillation competence NETwork/European Heart Rhythm Association consensus conference P Kirchhof, G Breithardt, E Aliot, S Al Khatib, S Apostolakis, A Auricchio, ... Europace 15 (11), 1540-1556, 2013 | 208 | 2013 |
| Recurrent unexplained palpitations (RUP) study: comparison of implantable loop recorder versus conventional diagnostic strategy F Giada, M Gulizia, M Francese, F Croci, L Santangelo, M Santomauro, ... Journal of the American College of Cardiology 49 (19), 1951-1956, 2007 | 172 | 2007 |
| Early rhythm control therapy in patients with atrial fibrillation and heart failure A Rillig, C Magnussen, AK Ozga, A Suling, A Brandes, G Breithardt, ... Circulation 144 (11), 845-858, 2021 | 143 | 2021 |
| Temporal trends in the epidemiology, management, and outcome of patients with cardiogenic shock complicating acute coronary syndromes L De Luca, Z Olivari, A Farina, L Gonzini, D Lucci, A Di Chiara, G Casella, ... European journal of heart failure 17 (11), 1124-1132, 2015 | 133 | 2015 |
| Prospective multicentre systematic guideline-based management of patients referred to the Syncope Units of general hospitals M Brignole, A Ungar, I Casagranda, M Gulizia, M Lunati, F Ammirati, ... Europace 12 (1), 109-118, 2010 | 129 | 2010 |
| Contemporary antithrombotic strategies in patients with acute coronary syndrome admitted to cardiac care units in Italy: The EYESHOT Study L De Luca, S Leonardi, C Cavallini, D Lucci, G Musumeci, R Caporale, ... European Heart Journal: Acute Cardiovascular Care 4 (5), 441-452, 2015 | 113 | 2015 |
| Current presentation and management of 7148 patients with atrial fibrillation in cardiology and internal medicine hospital centers: the ATA AF study G Di Pasquale, G Mathieu, AP Maggioni, G Fabbri, D Lucci, G Vescovo, ... International journal of cardiology 167 (6), 2895-2903, 2013 | 105 | 2013 |
| Rationale and current perspective for early rhythm control therapy in atrial fibrillation IC Van Gelder, LM Haegeli, A Brandes, H Heidbuchel, E Aliot, J Kautzner, ... Europace 13 (11), 1517-1525, 2011 | 104 | 2011 |
